BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 22507795)

  • 1. Myeloma: diagnosis complications and supportive care.
    Morgan G
    Hematology; 2012 Apr; 17 Suppl 1():S109-11. PubMed ID: 22507795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Supportive care in multiple myeloma for continuing anti-myeloma therapies].
    Shibayama H
    Rinsho Ketsueki; 2014 Oct; 55(10):1999-2004. PubMed ID: 25297765
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful bone reconstruction after bortezomib therapy in a myeloma patient.
    Tanaka T; Yamasaki R; Omura H; Hino N
    Int J Hematol; 2011 Sep; 94(3):221. PubMed ID: 21861100
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multiple myeloma].
    Abe M
    Nihon Rinsho; 2009 May; 67(5):991-5. PubMed ID: 19432122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloma: making sense of a complex blood cancer.
    Kelly MB; Meenaghan T; Dowling M
    Br J Nurs; 2010 Dec 9-2011 Jan 13; 19(22):1415-21. PubMed ID: 21139523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple myeloma.
    Laubach J; Richardson P; Anderson K
    Annu Rev Med; 2011; 62():249-64. PubMed ID: 21090965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orthopaedics: Structural support.
    Berglund J
    Nature; 2011 Dec; 480(7377):S56-7. PubMed ID: 22169807
    [No Abstract]   [Full Text] [Related]  

  • 8. Bortezomib alone or in combination with the histone deacetylase inhibitor JNJ-26481585: effect on myeloma bone disease in the 5T2MM murine model of myeloma.
    Deleu S; Lemaire M; Arts J; Menu E; Van Valckenborgh E; Vande Broek I; De Raeve H; Coulton L; Van Camp B; Croucher P; Vanderkerken K
    Cancer Res; 2009 Jul; 69(13):5307-11. PubMed ID: 19531653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current therapy of myeloma induced renal failure.
    Gertz MA
    Leuk Lymphoma; 2008 May; 49(5):833-4. PubMed ID: 18452070
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study of bortezomib in the treatment of multiple myeloma patients with renal failure].
    Cao ZG; Liu M; Zhou HW
    Zhonghua Xue Ye Xue Za Zhi; 2013 Jan; 34(1):74-5. PubMed ID: 23597473
    [No Abstract]   [Full Text] [Related]  

  • 11. Bortezomib just for induction or also for maintenance in myeloma patients with renal impairment?
    San Miguel JF
    Haematologica; 2014 Jan; 99(1):5-6. PubMed ID: 24425688
    [No Abstract]   [Full Text] [Related]  

  • 12. Bortezomib induced a phrenic palsy in a multiple myeloma patient.
    Nizeica V; Collet P; Marotte H
    Ann Hematol; 2013 Aug; 92(8):1135-6. PubMed ID: 23370597
    [No Abstract]   [Full Text] [Related]  

  • 13. Supportive therapy in multiple myeloma.
    Ludwig H; Zojer N
    Recent Results Cancer Res; 2011; 183():307-33. PubMed ID: 21509692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Update in multiple myeloma: international criteria for treatment response and renal complications].
    Decaux O; Karras A
    Rev Med Interne; 2009 Dec; 30(12):1080-3. PubMed ID: 19833418
    [No Abstract]   [Full Text] [Related]  

  • 15. Current treatments for renal failure due to multiple myeloma.
    Kastritis E; Terpos E; Dimopoulos MA
    Expert Opin Pharmacother; 2013 Aug; 14(11):1477-95. PubMed ID: 23705905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety evaluation of bortezomib in multiple myeloma patients with severe renal failure].
    Muta T; Nakanishi H; Yasunaga M; Senba S; Murakami H; Kan S; Ueda Y; Fujisaki T
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):237-41. PubMed ID: 21368487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
    Dimopoulos MA; Roussou M; Gavriatopoulou M; Zagouri F; Migkou M; Matsouka C; Barbarousi D; Christoulas D; Primenou E; Grapsa I; Terpos E; Kastritis E
    Clin Lymphoma Myeloma; 2009 Aug; 9(4):302-6. PubMed ID: 19717380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments with bortezomib in treating multiple myeloma.
    Reddy GK
    Clin Lymphoma; 2004 Mar; 4(4):215-6. PubMed ID: 15072611
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of bortezomib on bone disease in multiple myeloma.
    Drake MT; Rajkumar SV
    Am J Hematol; 2009 Jan; 84(1):1-2. PubMed ID: 19030185
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current perspectives in the treatment of multiple myeloma - news and views].
    Knop S
    Dtsch Med Wochenschr; 2012 Mar; 137(13):636-9. PubMed ID: 22434170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.